Latest Biotech News

Aerska Therapeutics secured $39 million in follow‑on financing to advance its brain‑shuttle platform that ferries siRNA past the blood‑brain barrier by hitching payloads to antibodies mimicking...

Eli Lilly expanded its long‑standing relationship with Innovent Biologics through a new collaboration focused on oncology and immunology programs, featuring $350 million in upfront payments and...

The United Arab Emirates announced a partnership with Colossal Biosciences to establish the Colossal BioVault and World Preservation Lab at Dubai’s Museum of the Future, a nine‑figure initiative...

Roivant Sciences’ Priovant Therapeutics reported that brepocitinib, a dual JAK1/TYK2 inhibitor licensed from Pfizer, met proof‑of‑concept goals in cutaneous sarcoidosis — a rare inflammatory skin...

Eli Lilly agreed to acquire Orna Therapeutics for up to $2.4 billion to add an in‑vivo CAR‑T platform built on engineered circular RNA and lipid nanoparticle delivery. Orna’s lead program,...

Roche disclosed phase 3 results showing its BTK inhibitor fenebrutinib was non‑inferior to Ocrevus (ocrelizumab) in primary progressive multiple sclerosis (PPMS), reducing the risk of confirmed...

Takeda signed a multiyear R&D partnership with San Diego‑based Iambic to accelerate small‑molecule discovery across oncology, gastrointestinal and inflammation targets. The collaboration will...

Novo Nordisk filed suit against telehealth company Hims & Hers alleging infringement of semaglutide (Wegovy) patents, and signaled it may seek 'hundreds of millions' in damages. The complaint...

Eli Lilly expanded its collaboration with China’s Innovent Biologics under a deal worth up to $8.8 billion, including $350 million in upfront payments to jointly develop oncology and immunology...

Aerska Therapeutics, a startup developing 'brain shuttle' technology to deliver larger molecules across the blood‑brain barrier, raised $39 million in a follow‑on financing, the company told STAT....

Researchers reported in Nature Communications that combining bacteriophage therapy with traditional antibiotics cleared refractory Klebsiella pneumoniae peritonitis in a preclinical model of...

A sector briefing from Catalent and industry analysts highlighted the acute complexity of cell and gene therapy (CGT) supply chains—ranging from collection and chain‑of‑identity to manufacturing,...

Las Vegas police arrested an Israeli citizen following a raid on an alleged illicit biolab where multiple people reportedly became 'deathly ill.' Authorities seized more than 1,000 samples,...

OpenEvidence reached a reported $12 billion valuation as investors rewarded rapid clinician adoption of its AI medical search tool, which the company says is used regularly by more than 430,000...

Eli Lilly agreed to expand its collaboration with Innovent Biologics via a new deal that includes a $350 million upfront payment to develop oncology and immunology programs. The agreement—reported...

Telehealth firm Hims & Hers said it will stop offering a compounded version of Novo Nordisk’s Wegovy following legal pressure from regulators and industry challengers. The company faced federal...

Roivant Sciences’ subsidiary Priovant Therapeutics reported that brepocitinib, a dual JAK1/TYK2 inhibitor licensed from Pfizer, met the goals of a proof‑of‑concept study in cutaneous sarcoidosis....

Sanofi presented data from a failed Phase 3 trial of the BTK inhibitor tolebrutinib in primary progressive multiple sclerosis (PPMS), explaining the company’s decision to withdraw from that...

Las Vegas police arrested an Israeli national and seized more than 1,000 samples and laboratory equipment from a residential property after several people reported becoming “deathly ill,”...

Researchers published a Nature Communications study showing a combination of bacteriophages and antibiotics effectively treated refractory peritoneal dialysis‑related peritonitis caused by...